Last 12 months
Inside the activity.
13 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 9 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 4 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2018 Filed Jul 26, 2018 18:12 UTC |
MARIO ERNESTDirector
|
GrantCommon Stock, par value $.0001 | 4,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-18-000822 · doc4_5553.xml · nonDerivative · entry 1 MARIO ERNEST · CIK 0001180469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,770 F1 · shares: Represents restricted stock units that vest on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 17:34 UTC |
Clauson LukeVP, Research and Development
|
GrantStock Option (right to buy) · Derivative | 19,874 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000812 · doc4_5547.xml · derivative · entry 1 Clauson Luke · CIK 0001736840 · VP, Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,874 Underlying: Common Stock · 19,874 shares Expires 2028-07-24 F1 · derivative.exercise_date: One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24-one month anniversaries thereafter. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 17:33 UTC |
Clasby Jennifer GVP, Clinical Operations
|
GrantStock Option (right to buy) · Derivative | 19,874 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000811 · doc4_5546.xml · derivative · entry 1 Clasby Jennifer G · CIK 0001728919 · VP, Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,874 Underlying: Common Stock · 19,874 shares Expires 2028-07-24 F1 · derivative.exercise_date: One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24-one month anniversaries thereafter. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 18:12 UTC |
LEE KENNETH B JRDirector
|
GrantStock Option (right to buy) · Derivative | 4,465 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000821 · doc4_5551.xml · derivative · entry 2 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,465 Underlying: Common Stock · 4,465 shares Expires 2028-07-24 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 18:12 UTC |
LEE KENNETH B JRDirector
|
GrantCommon Stock, par value $.0001 | 4,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-18-000821 · doc4_5551.xml · nonDerivative · entry 1 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,033 F1 · shares: Represents restricted stock units that vest on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 17:33 UTC |
GANDOLFO JOHN PChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 24,842 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000810 · doc4_5544.xml · derivative · entry 2 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,842 Underlying: Common Stock · 24,842 shares Expires 2028-07-24 F1 · derivative.exercise_date: One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24-one month anniversaries thereafter. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 18:12 UTC |
MATHER CHARLES E IVDirector
|
GrantStock Option (right to buy) · Derivative | 4,465 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000820 · doc4_5549.xml · derivative · entry 2 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,465 Underlying: Common Stock · 4,465 shares Expires 2028-07-24 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 18:12 UTC |
MATHER CHARLES E IVDirector
|
GrantCommon Stock, par value $.0001 | 4,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-18-000820 · doc4_5549.xml · nonDerivative · entry 1 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,033 F1 · shares: Represents restricted stock units that vest on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 21:33 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
GrantStock Option (right to buy) · Derivative | 124,210 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000808 · doc4_5542.xml · derivative · entry 5 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,210 Underlying: Common Stock · 124,210 shares Expires 2028-07-24 F2 · derivative.exercise_date: One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24-one month anniversaries thereafter. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 21:33 UTC |
Rowe Michael MVice President of Marketing
|
GrantStock Option (right to buy) · Derivative | 19,874 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000809 · doc4_5545.xml · derivative · entry 2 Rowe Michael M · CIK 0001744774 · Vice President of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,874 Underlying: Common Stock · 19,874 shares Expires 2028-07-24 F1 · derivative.exercise_date: One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24-one month anniversaries thereafter. Read SEC document |
| July 24, 2018 Filed Jul 30, 2018 17:20 UTC |
SUN ANTHONY YDirector
|
GrantStock Option (right to buy) · Derivative | 4,465 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000864 · doc4_5550.xml · derivative · entry 2 SUN ANTHONY Y · CIK 0001377952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,465 Underlying: Common Stock · 4,465 shares Expires 2028-07-24 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| July 24, 2018 Filed Jul 30, 2018 17:20 UTC |
SUN ANTHONY YDirector
|
GrantCommon Stock, par value $.0001 | 4,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001638599-18-000864 · doc4_5550.xml · nonDerivative · entry 1 SUN ANTHONY Y · CIK 0001377952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,033 F1 · shares: Represents restricted stock units that vest on the earlier of July 24, 2019 or the date of the Issuer's 2019 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 18:14 UTC |
Rowe Michael MVice President of Marketing
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001638599-18-000721 · doc4_5497.xml · derivative · entry 2 Rowe Michael M · CIK 0001744774 · Vice President of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2028-07-02 F1 · derivative.exercise_date: The option becomes exercisable as to 1,666 shares on August 2, 2018, and becomes exercisable in equal 1,666 share amounts on each of the 35 one-month anniversaries thereafter. Read SEC document |
| June 28, 2018 Filed Jul 2, 2018 16:06 UTC |
GANDOLFO JOHN PChief Financial Officer
|
PurchaseCommon Stock, par value $.0001 | 2,000 | $5.86 | $11,720.00 |
DisclosureSEC source: 0001638599-18-000709 · doc4_5498.xml · nonDerivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| June 28, 2018 Filed Jul 2, 2018 20:05 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock, par value $.0001 | 6,000 | $6.63 | $39,780.00 |
DisclosureSEC source: 0001638599-18-000707 · doc4_5504.xml · nonDerivative · entry 1 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By The Meliora Trust Disclosed balance after: 6,000 F1 · price: This transaction was executed in multiple trades ranging from $6.35 to $6.73. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 16:33 UTC |
GANDOLFO JOHN PChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 71,200 | $0.00 Strike: $8.72 | $0.00 |
DisclosureSEC source: 0001638599-18-000439 · doc4_5363.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,200 Underlying: Common Stock · 71,200 shares Expires 2028-04-16 F1 · derivative.exercise_date: The option becomes exercisable as to 1,977 shares on May 16, 2018, and becomes exercisable in equal 1,977 share amounts on each of the 35 one-month anniversaries thereafter. Read SEC document |
| January 29, 2018 Filed Feb 6, 2018 10:00 UTC |
ESHELMAN FREDRIC NDirector · 10% owner
|
PurchaseCommon Stock, par value $.0001 | 335,000 | $10.00 | $3,350,000.00 |
DisclosureSEC source: 0001144204-18-005875 · tv484957_4.xml · nonDerivative · entry 1 ESHELMAN FREDRIC N · CIK 0001033409 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,273,428 Read SEC document |
| January 29, 2018 Filed Feb 6, 2018 15:04 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock, par value $.0001 | 10,000 | $10.00 | $100,000.00 |
DisclosureSEC source: 0001144204-18-005879 · tv484963_4.xml · nonDerivative · entry 1 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,749 Read SEC document |
| January 29, 2018 Filed Feb 8, 2018 15:37 UTC |
LaBelle Curt HDirector · 10% owner
|
PurchaseCommon Stock, par value $.0001 | 10,000 | $10.00 | $100,000.00 |
DisclosureSEC source: 0001144204-18-006591 · tv484955_4.xml · nonDerivative · entry 1 LaBelle Curt H · CIK 0001396235 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| January 29, 2018 Filed Feb 9, 2018 10:34 UTC |
Yoshida ShuheiDirector · 10% owner
|
PurchaseCommon Stock, par value $.0001 | 100,000 | $10.00 | $1,000,000.00 |
DisclosureSEC source: 0001144204-18-006804 · tv484961_4.xml · nonDerivative · entry 1 Yoshida Shuhei · CIK 0001728901 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Senju Pharmaceuticals Co., Ltd. Disclosed balance after: 1,718,566 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 29, 2018 Filed Feb 9, 2018 15:25 UTC |
Senju Pharmaceutical Co., Ltd.10% owner
|
PurchaseCommon Stock, par value $.0001 | 100,000 | $10.00 | $1,000,000.00 |
DisclosureSEC source: 0001144204-18-006799 · tv484959_4.xml · nonDerivative · entry 1 Senju Pharmaceutical Co., Ltd. · CIK 0001728986 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,718,566 Read SEC document |
| January 29, 2018 Filed May 21, 2019 17:24 UTC |
MARIO ERNESTDirector
|
PurchaseCommon Stock, par value $.0001 | 90,000 | $10.00 | $900,000.00 |
DisclosureSEC source: 0001638599-19-000539 · doc4_6117.xml · nonDerivative · entry 1 MARIO ERNEST · CIK 0001180469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,770 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.